These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3215457)

  • 41. PFC as blood substitutes--an overview.
    Geyer RP
    Prog Clin Biol Res; 1983; 122():157-68. PubMed ID: 6878357
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of exchange transfusion with a red blood cell substitute on the neonatal lung.
    Breuninger HG; Wolfson MR; Rubenstein SD; Shaffer TH
    J Dev Physiol; 1990 Nov; 14(5):283-9. PubMed ID: 2100743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Electron microscopic detections on emulsions of perfluorocarbon blood substitute (author's transl)].
    Dai ZQ
    Zhongguo Yao Li Xue Bao; 1982 Mar; 3(1):35-7. PubMed ID: 6211901
    [No Abstract]   [Full Text] [Related]  

  • 44. Compatibility of different colloid plasma expanders with perflubron emulsion: an intravital microscopic study in the hamster.
    Nolte D; Pickelmann S; Lang M; Keipert P; Messmer K
    Anesthesiology; 2000 Nov; 93(5):1261-70. PubMed ID: 11046215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vasoreactivity of Fluosol perfluorocarbon emulsion vs. Earl's balanced salt/albumin perfusates in the isolated perfused rat lung.
    Mullett CJ; Polak MJ
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):449-57. PubMed ID: 7493066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A system establishment compatibility profiles for artificial oxygen carriers and other substances.
    Dinkelmann S; Röhlke W; Meinert H; Northoff H
    Artif Cells Blood Substit Immobil Biotechnol; 2001 Jan; 29(1):57-70. PubMed ID: 11280685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Perfluorocarbon emulsions and other corpuscular systems influence on neutrophil activity].
    Shekhtman DG; Safronova VG; Sklifas AN; Alovskaia AA; Gapeev AB; Obraztsov VV; Chemeris NK
    Biofizika; 1997; 42(6):1260-6. PubMed ID: 9490112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of perfluorodecalin as an oxygen carrier on actinorhodin production by Streptomyces coelicolor A3(2).
    Elibol M; Mavituna F
    Appl Microbiol Biotechnol; 1995; 43(2):206-10. PubMed ID: 7612244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Rheological behavior of blood substitutes with a perfluorocarbon base].
    Draffehn J; Reichelt H
    Pharmazie; 1991 Nov; 46(11):800-2. PubMed ID: 1725823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stability of perfluorocarbon blood substitutes determined by sedimentation field-flow fractionation.
    Yang FS; Caldwell KD; Giddings JC; Astle L
    Anal Biochem; 1984 May; 138(2):488-94. PubMed ID: 6742424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perfluorochemical erythrocyte substitutes: disposition and effects on drug distribution and elimination.
    Ravis WR; Hoke JF; Parsons DL
    Drug Metab Rev; 1991; 23(3-4):375-411. PubMed ID: 1935577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Collateral oxygenation of the ischemic myocardium: the effect of viscosity and oxygen carrying fluorocarbons.
    Faithfull NS; Fennema M; Essed CE; Erdmann W; Jeekel H; Lapin R
    Prog Clin Biol Res; 1983; 122():229-36. PubMed ID: 6878365
    [No Abstract]   [Full Text] [Related]  

  • 53. Rheology of concentrated perfluorocarbon emulsions.
    Ni Y; Klein DH; Pelura TJ
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):869-71. PubMed ID: 1391526
    [No Abstract]   [Full Text] [Related]  

  • 54. Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes.
    Tao Z; Ghoroghchian PP
    Trends Biotechnol; 2014 Sep; 32(9):466-73. PubMed ID: 24929580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Introduction to fluorocarbons.
    Clark LC
    Int Anesthesiol Clin; 1985; 23(1):1-9. PubMed ID: 3980100
    [No Abstract]   [Full Text] [Related]  

  • 56. [Morphological changes in erythrocytes exposed to perfluorodecalin and oxygenation].
    Skorik VI; Novozhilova AP; Sudus AV; Shilov VV
    Biull Eksp Biol Med; 1995 Nov; 120(11):535-9. PubMed ID: 8713338
    [No Abstract]   [Full Text] [Related]  

  • 57. [Hemoprotective effect of perfluorodecalin].
    Skorik VI; Sudus AV; Shilov VV; Zhiburt EB; Vashchenko VI; Rozhdestvenskaia EN
    Biull Eksp Biol Med; 1996 May; 121(5):512-5. PubMed ID: 8744124
    [No Abstract]   [Full Text] [Related]  

  • 58. Side reaction caused by the perfluorocarbon emulsions in intravenous infusion to experimental animals.
    Sedova LA; Kochetygov NI; Berkos MV; Pjatowskaja NN
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Mar; 26(2):149-57. PubMed ID: 9564433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxygen delivery and performance in the isolated, perfused rat heart: comparison of perfusion with aqueous and perfluorocarbon-containing media.
    Biro GP; Masika M; Korecky B
    Adv Exp Med Biol; 1989; 248():509-16. PubMed ID: 2506742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modeling of oxygen uptake in perfluorocarbon emulsions. Some comparisons with uptake by blood.
    Shah N; Mehra A
    ASAIO J; 1996; 42(3):181-9. PubMed ID: 8725685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.